Basel, Switzerland, 6 May 2025 - Luminance Health made a strong impact at Swiss Biotech Day 2025, one of Europe’s premier life sciences events, held in Basel on 5-6 May. With more than 3,000 senior experts from the biotech and life sciences industry and over 130 exhibitors, the event highlighted global innovation and collaboration in biotechnology.

The Luminance Health team engaged with international biotech leaders, start-ups, and innovators, showcasing its deep expertise in regulatory affairs, quality assurance, pharmacovigilance, medical devices, market access, and more. Attendees were welcomed to explore Luminance Health’s holistic approach to supporting life science companies at all stages of growth, whether navigating early development, scaling across borders, or entering the EU and Swiss markets.

Swiss Biotech Day served as a critical platform for connecting with industry leaders and pioneering new pathways for innovation in healthcare. Luminance Health shared its expertise while learning from others who are shaping the future of biotech.

Pioneering Conversations on Advanced Therapies

Luminance Health also hosted an insightful panel discussion titled “Advanced Therapies: From Research to Patient Access – Opportunities & Challenges”. The panel explored the journey from groundbreaking research to real-world patient access, with a special focus on rare and complex diseases.

Moderated by Nathalie Schober-Ladani, the panel featured distinguished voices from the field:

• Julia Djonova, Swissmedic

• Ghada Ibrahim, PACRT – Geneva

• Thomas Eaton, Limula

• Joanna Hanley, Luminance Health

Discussions centered on overcoming regulatory and logistical barriers to bring life-changing therapies to market faster. The panel emphasized the importance of collaboration across the healthcare ecosystem to dismantle silos and accelerate patient access to innovative treatments.

The belief that meaningful innovation in healthcare extends beyond discovery to ensuring that innovations reach the patients who need them most was a central theme of the panel. Achieving this requires alignment across regulation, policy, and patient advocacy.

Building Bridges for Global Impact

The two-day event also featured thematic company pitching sessions, roundtable discussions, the Swiss Biotech Success Stories Awards, and the launch of the Swiss Biotech Report 2025. Luminance Health’s presence underscored its commitment to advancing global health through strategic partnerships and expert guidance.

As Swiss Biotech Day concluded, Luminance Health expressed gratitude for the inspiring conversations and new connections formed, reinforcing its dedication to leading transformative change in the life sciences sector.